| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy
|
Lin, Jianhong
|
|
|
128 |
2 |
p. 249-252
|
artikel
|
| 2 |
Acute myeloid leukemia with erythrophagocytosis indicative of KAT6A rearrangement
|
Montewis, Audrey
|
|
|
128 |
2 |
p. 314
|
artikel
|
| 3 |
ALPS DNT cells: active senior living with mTOR
|
Allen, Carl E.
|
|
|
128 |
2 |
p. 152
|
artikel
|
| 4 |
Amelanotic melanoma in the bone marrow
|
Kassam, Shireen
|
|
|
128 |
2 |
p. 313
|
artikel
|
| 5 |
A role for IFN during embryonic hematopoiesis
|
Essers, Marieke A.G.
|
|
|
128 |
2 |
p. 150-152
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
128 |
2 |
p. i
|
artikel
|
| 7 |
Fill 'er up? Fill what up?
|
Lollar, Pete
|
|
|
128 |
2 |
p. 156-157
|
artikel
|
| 8 |
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors
|
Hofbauer, Christoph J.
|
|
|
128 |
2 |
p. 293-296
|
artikel
|
| 9 |
How I treat patients with inherited bleeding disorders who need anticoagulant therapy
|
Martin, Karlyn
|
|
|
128 |
2 |
p. 178-184
|
artikel
|
| 10 |
Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
|
Völkl, Simon
|
|
|
128 |
2 |
p. 227-238
|
artikel
|
| 11 |
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
|
Lampson, Benjamin L.
|
|
|
128 |
2 |
p. 195-203
|
artikel
|
| 12 |
Interferon-α signaling promotes embryonic HSC maturation
|
Kim, Peter Geon
|
|
|
128 |
2 |
p. 204-216
|
artikel
|
| 13 |
Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice
|
Zriwil, Alya
|
|
|
128 |
2 |
p. 217-226
|
artikel
|
| 14 |
Mathé G, Amiel JL, Schwarzenberg L, et al. Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance, and possible anti-leukemic effects. Blood. 1965;25(2): 179-196.
|
|
|
|
128 |
2 |
p. 147
|
artikel
|
| 15 |
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera
|
Casu, Carla
|
|
|
128 |
2 |
p. 265-276
|
artikel
|
| 16 |
Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma
|
Matthews, Julie Marie
|
|
|
128 |
2 |
p. 239-248
|
artikel
|
| 17 |
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
|
Assouline, Sarit E.
|
|
|
128 |
2 |
p. 185-194
|
artikel
|
| 18 |
Pocket-sized iron regulators: one size fits all?
|
Subramaniam, V.Nathan
|
|
|
128 |
2 |
p. 153-154
|
artikel
|
| 19 |
Precision monitoring takes the stage
|
Roschewski, Mark
|
|
|
128 |
2 |
p. 149-150
|
artikel
|
| 20 |
Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B mice
|
Cooley, Brian
|
|
|
128 |
2 |
p. 286-292
|
artikel
|
| 21 |
Protease-activated receptors in hemostasis
|
Nieman, Marvin T.
|
|
|
128 |
2 |
p. 169-177
|
artikel
|
| 22 |
Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy
|
Moschoi, Ruxanda
|
|
|
128 |
2 |
p. 253-264
|
artikel
|
| 23 |
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
|
Sekine, Takuya
|
|
|
128 |
2 |
p. 297-312
|
artikel
|
| 24 |
Up or out: polarity of VWF release
|
Bierings, Ruben
|
|
|
128 |
2 |
p. 154-155
|
artikel
|
| 25 |
von Willebrand factor multimerization and the polarity of secretory pathways in endothelial cells
|
Lopes da Silva, Mafalda
|
|
|
128 |
2 |
p. 277-285
|
artikel
|
| 26 |
What is new in diagnosis and management of light chain amyloidosis?
|
Palladini, Giovanni
|
|
|
128 |
2 |
p. 159-168
|
artikel
|
Tijdschrift beschrijving